1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > North America Infectious Diagnostics Market Outlook to 2021

North America Infectious Diagnostics Market Outlook to 2021

  • October 2015
  • -
  • Global Data
  • -
  • 215 pages

North America Infectious Diagnostics Market Outlook to 2021

Summary

GlobalData’s new report, "North America Infectious Diagnostics Market Outlook to 2021", provides key market data on the North America Infectious Diagnostics market. The report provides value, in millions of US dollars within market segments - Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Infectious Diagnostics market includes Hepatitis Viruses, Retroviruses, Infectious Diagnostics Multiple Parameters Panels, Bacteriology, Nucleic Acid Testing Instruments, Other Virology, Infectious Diagnostics Rapid Tests & POC and Parasitology & Mycology.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Infectious Diagnostics market.
- Global corporate-level profiles of key companies operating within the North America Infectious Diagnostics market.
- Key players covered include Siemens Healthcare, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Hologic, Inc., Qiagen N.V., Becton, Dickinson and Company, Danaher Corporation and Alere Inc..

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

North America Infectious Diagnostics Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Infectious Diagnostics Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 11
3 Infectious Diagnostics Market, North America 13
3.1 Infectious Diagnostics Market, North America, Revenue ($m), 2007-2021 13
3.2 Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), 2007-2021 15
3.3 Infectious Diagnostics Market, North America, Revenue ($m), 2007-2014 17
3.4 Infectious Diagnostics Market, North America, Revenue ($m), 2014-2021 19
3.5 Infectious Diagnostics Market, North America, Company Share by Revenue ($m), 2014 21
4 Infectious Diagnostics Market, Canada 23
4.1 Infectious Diagnostics Market, Canada, Revenue ($m), 2007-2014 23
4.2 Infectious Diagnostics Market, Canada, Revenue ($m), 2014-2021 25
4.2.1 Infectious Diagnostics Rapid Tests and POC Market, Canada, Revenue ($m), by Segment, 2007-2014 27
4.2.2 Infectious Diagnostics Rapid Tests and POC Market, Canada, Revenue ($m), by Segment, 2014-2021 29
4.3 Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), 2013-2014 31
4.4 Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), 2014 32
5 Infectious Diagnostics Market, Mexico 34
5.1 Infectious Diagnostics Market, Mexico, Revenue ($m), 2007-2014 34
5.2 Infectious Diagnostics Market, Mexico, Revenue ($m), 2014-2021 36
5.2.1 Infectious Diagnostics Rapid Tests and POC Market, Mexico, Revenue ($m), by Segment, 2007-2014 38
5.2.2 Infectious Diagnostics Rapid Tests and POC Market, Mexico, Revenue ($m), by Segment, 2014-2021 40
5.3 Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), 2013-2014 42
5.4 Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), 2014 43
6 Infectious Diagnostics Market, United States 45
6.1 Infectious Diagnostics Market, United States, Revenue ($m), 2007-2014 45
6.2 Infectious Diagnostics Market, United States, Revenue ($m), 2014-2021 47
6.2.1 Infectious Diagnostics Rapid Tests and POC Market, United States, Revenue ($m), by Segment, 2007-2014 49
6.2.2 Infectious Diagnostics Rapid Tests and POC Market, United States, Revenue ($m), by Segment, 2014-2021 51
6.3 Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), 2013-2014 53
6.4 Infectious Diagnostics Market, United States, Company Share by Revenue ($m), 2014 54
7 Overview of Key Companies in North America Infectious Diagnostics Market 56
7.1 Hologic, Inc. 56
7.1.1 Company Overview 56
7.2 Abbott Laboratories 56
7.2.1 Company Overview 56
7.3 Qiagen N.V. 56
7.3.1 Company Overview 56
7.4 F. Hoffmann-La Roche Ltd. 57
7.4.1 Company Overview 57
7.5 Becton, Dickinson and Company 57
7.5.1 Company Overview 57
7.6 Siemens Healthcare 57
7.6.1 Company Overview 57
7.7 Danaher Corporation 58
7.7.1 Company Overview 58
7.8 Alere Inc. 58
7.8.1 Company Overview 58
7.9 bioMerieux S.A. 58
7.9.1 Company Overview 58
7.10 DiaSorin S.p.A 59
7.10.1 Company Overview 59
7.11 Cepheid 59
7.11.1 Company Overview 59
8 Infectious Diagnostics Market Pipeline Products 60
9 Financial Deals Landscape 78
9.1 Partnerships 78
9.1.1 Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics 78
10 Recent Developments 79
10.1 Corporate Communications 79
10.1.1 Aug 19, 2015: Quidel Announces Changes to Board of Directors 79
10.1.2 Aug 17, 2015: MedMira Board Reinforces Biotech Bench Strength with New Appointment 79
10.1.3 Jul 08, 2015: Aethlon Medical Announces Nasdaq Capital Market Listing Approval 80
10.1.4 Jun 25, 2015: Cardiac Dimensions Announces Initial Enrollments in REDUCE FMR Clinical Trial 80
10.1.5 Jun 25, 2015: CombiMatrix Expands Sales Team to Accelerate Entry Into New Markets 81
10.1.6 Jun 22, 2015: InVivo Therapeutics Receives Notice of Allowance on Patent Covering Broader Compositions for Neuro-Spinal Scaffold and Neuro-Spinal Scaffold Plus Stem Cells 81
10.1.7 Jun 18, 2015: Dutch hospital acquires 1,000th Agility, Elekta's radiotherapy beam-shaping technology for treating cancer 82
10.1.8 Jun 17, 2015: Newly FDA-Approved Device for Stroke Prevention Available at Mercy 84
10.1.9 Jun 09, 2015: Aethlon Medical Announces Resignation of Inside Director to Comply with NASDAQ Corporate Governance Requirements 84
10.1.10 May 06, 2015: ERBA Diagnostics Appoints Ernesina Scala as Chief Financial Officer and Chandra Krishnan as Senior Vice President Global Sales, Marketing and Business Development 85
10.1.11 Apr 07, 2015: Cepheid Welcomes Executive Vice President And Chief Financial Officer 85
10.1.12 Mar 18, 2015: Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer 86
10.1.13 Mar 16, 2015: CombiMatrix Appoints Lale White to Board of Directors 87
10.1.14 Mar 05, 2015: New Study in Journal of Tissue Viability Recognizes SEM Scanner's Clinical Utility in Detection of Pressure Ulcers 87
10.1.15 Mar 03, 2015: SQI Diagnostics Appoints Chief Financial Officer 88
10.1.16 Jan 20, 2015: CombiMatrix Names Karen Warner, RN, Vice President of Reimbursement 89
10.1.17 Jan 08, 2015: Quest Diagnostics Names New Health Plan Leader 90
10.1.18 Jan 08, 2015: Chembio Appoints Paul Lambotte as Vice President, Product Development 90
10.1.19 Jan 06, 2015: Former President of BIO Joins Trovagene's Board of Directors 91
10.1.20 Nov 19, 2014: CombiMatrix Promotes Karine Hovanes, Ph.D., To Vice President Of Scientific Advancement And Laboratory Director, And Trilochan Sahoo, M.D., To Vice President Of Clinical Affairs And Director Of Cytogenetics 92
10.1.21 Nov 18, 2014: Dr. Kenneth J. Widder Joins Quidel's Board of Directors 92
10.1.22 Nov 10, 2014: C3 Jian Adds Two Top Oral Healthcare Professionals To Its Board Of Directors 93
10.1.23 Nov 04, 2014: MedMira Names Robyn Cook As Chief Corporate Officer 94
10.1.24 Oct 29, 2014: Lucigen Announces Ralph Kauten as CEO 94
10.1.25 Oct 22, 2014: Quest Diagnostics Adds Jeffrey M. Leiden, M.D., Ph.D., to Board of Directors 95
10.1.26 Oct 15, 2014: Luminex Announces Retirement of Patrick Balthrop, President and CEO 95
10.1.27 Oct 02, 2014: 3-V Biosciences To Present Clinical And Preclinical Data For FASN Inhibitors At EORTC-NCI-AACR 2014 96
10.1.28 Oct 01, 2014: Quest Diagnostics Names Mayo Clinic Executive Franklin R. Cockerill, M.D., Vice President and Chief Laboratory Officer 97
10.1.29 Sep 29, 2014: SQI Diagnostics Announces New Chairman of Board of Directors 99
10.1.30 Sep 24, 2014: Spectral announces board changes 99
10.2 Financial Announcements 99
10.2.1 Aug 25, 2015: High Throughput Single-Cell mRNA Sequencing Preparation Comes to the Fluidigm C1 System 99
10.2.2 Aug 25, 2015: SPR Therapeutics Awarded $1.6M NIH Grant to Study Pain Management Following Knee Replacement Surgery Using the Sprint PNS System 100
10.2.3 Aug 25, 2015: Xtant Medical Announces FDA Approval of OsteoSelect PLUS 103
10.2.4 Aug 25, 2015: Multi-center ALS Study Using the NeuRx Diaphragm Pacing System Shows Safety and Survival Post-Implant of 20.9 Months 105
10.2.5 Aug 18, 2015: SQI Diagnostics Reports Third Quarter Financial Results 107
10.2.6 Aug 14, 2015: Spectral Announces Second Quarter 2015 Results 109
10.2.7 Aug 13, 2015: Aethlon Medical Announces Fiscal 2016 First Quarter Results 109
10.2.8 Aug 10, 2015: Trovagene Announces Second Quarter 2015 Financial Results 111
10.2.9 Aug 06, 2015: Chembio Diagnostics Reports Second Quarter Financial Results 112
10.2.10 Aug 05, 2015: ERBA Diagnostics Reports 2nd Quarter 2015 Financial Results 114
10.2.11 Aug 04, 2015: CombiMatrix Reports Second Quarter 2015 Financial and Operating Results 115
10.2.12 Aug 03, 2015: Luminex Reports Record 2nd Quarter 2015 Results 117
10.2.13 Jul 28, 2015: Neogen's new NeoSal designed to simplify oral fluid collection 118
10.2.14 Jul 27, 2015: Neogen launches NeoSeek Salmonella serotyping service 119
10.2.15 Jul 23, 2015: Quest Diagnostics Reports Second Quarter 2015 Financial Results 120
10.2.16 Jul 23, 2015: Cepheid Reports 2015 Second Quarter Results 122
10.2.17 Jul 22, 2015: Quidel Reports Second Quarter 2015 Financial Results 122
10.2.18 Jun 26, 2015: ERBA Diagnostics Reports 1st Quarter 2015 Financial Results 124
10.2.19 Jun 17, 2015: Derma Sciences Announces Medicare Coverage Reinstated For MEDIHONEY Products with Reimbursable Codes by Centers for Medicare and Medicaid Services 125
10.2.20 Jun 03, 2015: Sirona Biochem CEO Update: Significant Interest from Top Cosmetic and Pharmaceutical Companies for Lead Compounds 126
10.2.21 May 21, 2015: SQI Diagnostics Reports Second Quarter Financial Results 129
10.2.22 May 18, 2015: ERBA Diagnostics Reports 2014 Financial Results; Announces Delay in Filing Quarterly Report on Form 10-Q 131
10.2.23 May 13, 2015: Spectral Announces First Quarter 2015 Results 133
10.2.24 May 09, 2015: Shanghai MicroPort Orthopedics Hosts First SuperPath Online Symposium 133
10.2.25 May 07, 2015: Chembio Diagnostics Reports First Quarter 2015 Financial Results 134
10.2.26 May 07, 2015: CombiMatrix Reports First Quarter 2015 Financial and Operating Results 135
10.2.27 May 06, 2015: ARIAD Announces Commercial Distribution Agreement for Iclusig (ponatinib) in Turkey 137
10.2.28 May 05, 2015: Trovagene Announces First Quarter 2015 Financial Results 139
10.2.29 May 04, 2015: Luminex Reports First Quarter 2015 Results 140
10.2.30 Apr 23, 2015: Quidel Reports First Quarter 2015 Financial Results 140
10.2.31 Apr 23, 2015: Quest Diagnostics Reports First Quarter 2015 Financial Results 141
10.2.32 Apr 23, 2015: Cepheid Reports 2015 First Quarter Results 142
10.2.33 Mar 25, 2015: Spectral Announces Fourth Quarter and Fiscal 2014 Results 142
10.2.34 Mar 20, 2015: MedMira Reports Second Quarter Financial Results 143
10.2.35 Mar 19, 2015: AHN Offers Innovative Minimally-Invasive Surgical Procedure for Patients with Common, Yet Difficult to Diagnose, Form of Recurring Back Pain 143
10.2.36 Mar 18, 2015: Blue Belt Technologies Announces First Navio Case Performed in Australia and First Navio-assisted GRU Unicompartmental Knee Replacement 144
10.2.37 Mar 17, 2015: LG Health receives first upgrade to its CyberKnife M6 System 146
10.2.38 Mar 17, 2015: Mediware to Unveil CareTend Software at NHIA Conference 146
10.2.39 Mar 13, 2015: Patients With Prostate Cancer Face an Uncertainty in Their Future Treatment After NHS England Decision 148
10.2.40 Mar 12, 2015: Trovagene Reports Fourth Quarter and Full Year 2014 Financial Results 150
10.2.41 Mar 05, 2015: Mazor Robotics Renaissance Guidance System Helping Patients with OCD 152
10.2.42 Mar 05, 2015: Chembio Diagnostics Reports 2014 Financial Results 154
10.2.43 Mar 04, 2015: Exact Sciences Announces Aetna Medicare Advantage to Cover Cologuard 156
10.2.44 Mar 04, 2015: Myriad Publishes myPath Melanoma Pivotal Validation Study in the Journal of Cutaneous Pathology 158
10.2.45 Mar 04, 2015: PositiveID Corporation Files U.S. Patent for Its Firefly Dx Real-Time PCR System 160
10.2.46 Mar 03, 2015: Oxford Immunotec Reports Fourth Quarter and Full Year 2014 Financial Results 162
10.2.47 Feb 26, 2015: SQI Diagnostics Reports First Quarter Financial Results 164
10.2.48 Feb 25, 2015: CombiMatrix Reports Fourth Quarter and Full Year 2014 Financial and Operating Results 165
10.2.49 Feb 20, 2015: Neuronetrix receives FDA clearance to market COGNISION for use in the clinic 167
10.2.50 Feb 12, 2015: FDA Classifies Previous Covidien Field Action for Its Trellis-6 Peripheral Infusion Systems As a Class 1 Recall 170
10.2.51 Feb 11, 2015: Quidel Reports Fourth Quarter and Full Year 2014 Financial Results 170
10.2.52 Feb 10, 2015: Aethlon Medical Reports Q3 Fiscal 2015 Results 172
10.2.53 Feb 02, 2015: Luminex Reports Fourth Quarter And Full Year 2014 Results 173
10.2.54 Jan 29, 2015: Cepheid Reports Fourth Quarter And Full Year 2014 Results 174
10.2.55 Jan 29, 2015: Quest Diagnostics Reports Fourth Quarter and Full Year 2014 Financial Results; Provides Guidance For Full Year 2015; Increases Dividend 15% 175
10.2.56 Dec 31, 2014: MicroPort Completes First Implantation of Reewarm18 176
10.2.57 Dec 24, 2014: MedMira Reports First Quarter Results 177
10.2.58 Dec 17, 2014: SQI Diagnostics Reports Fourth Quarter and Fiscal 2014 Results 178
10.2.59 Nov 28, 2014: MedMira Reports 2014 Fourth Quarter And Year End Financial Results 180
10.2.60 Nov 24, 2014: Volpara Solutions to Launch VolparaAnalytics 1.2 at RSNA 180
10.2.61 Nov 13, 2014: Spectral Announces Third Quarter 2014 Results 182
10.2.62 Nov 10, 2014: ERBA Diagnostics Reports 3rd Quarter Financial Results 182
10.2.63 Nov 10, 2014: Aethlon Medical Reports Q2 Fiscal 2015 Results 183
10.2.64 Nov 06, 2014: Trovagene Announces Third Quarter 2014 Financial Results 185
10.2.65 Nov 06, 2014: Chembio Diagnostics Reports Third Quarter 2014 Financial Results 186
10.2.66 Nov 04, 2014: CombiMatrix Reports Third Quarter 2014 Financial and Operating Results 187
10.2.67 Oct 27, 2014: Luminex Reports Third Quarter 2014 Results 189
10.2.68 Oct 23, 2014: Quest Diagnostics Reports Third Quarter 2014 Financial Results 190
10.2.69 Oct 21, 2014: Quidel Reports Third Quarter 2014 Financial Results 191
10.2.70 Oct 16, 2014: Cepheid Reports 2014 Third Quarter Results 193
10.2.71 Oct 07, 2014: CombiMatrix Reports Preliminary Growth in Prenatal Microarray Testing Volumes of 71% and 64% for the Third Quarter and Year-to-Date, Respectively 193
10.3 Government and Public Interest 194
10.3.1 Jan 26, 2015: Trovagene's Chief Scientific Officer to Present Precision Cancer Monitoring Platform Overview at the Personalized Medicine World Conference 194
10.4 Legal And Regulatory 194
10.4.1 Jul 06, 2015: Enzo Biochem Reaches $7.1 Million Patent Infringement Settlement with Luminex 194
10.4.2 Apr 28, 2015: CombiMatrix Executes Final Settlement Ending Litigation 195
10.4.3 Mar 12, 2015: Superior Court Issues Final Statement of Decision and Enters Judgment in Favor of CombiMatrix 195
10.4.4 Jan 06, 2015: Superior Court Issues Tentative Ruling and Proposed Statement of Decision in Favor of CombiMatrix 196
10.5 Other Significant Developments 196
10.5.1 May 05, 2015: Lucigen Expands Technological Reach with Exclusive Sigma-Aldrich Distribution Agreement 196
10.5.2 Mar 19, 2015: Sigma-Aldrich Announces Exclusive Distribution Agreement with Roche 197
10.5.3 Mar 19, 2015: CombiMatrix Announces Payor Contract With InterWest Health 197
10.5.4 Feb 10, 2015: Rheonix Receives $1.5 Million SBIR Phase II Grant from the National Institute of Dental and Craniofacial Research of the National Institutes of Health 198
10.5.5 Jan 28, 2015: Two of MedMira's Multiplo Tests Procured for UNAIDS Program in Central Asia 199
10.5.6 Jan 26, 2015: Erba Diagnostics Expands U.S. Distribution Network 199
10.5.7 Dec 16, 2014: Spectral Announces Effective Date of Name Change 200
10.5.8 Dec 15, 2014: SQI Diagnostics Wins Additional Business from UK-based Customer 200
10.5.9 Dec 04, 2014: Quest Diagnostics Declares Quarterly Cash Dividend 201
10.5.10 Nov 05, 2014: Bearing Analytics Changes Name To DATTUS, Opens Office In India 201
10.6 Product News 202
10.6.1 Jun 25, 2015: Study Published In May Issue Of Journal Of Dermatologic Surgery Demonstrates Significant Improvement In Face And Neck Treatment Results From New Profound Non-Surgical Procedure 202
10.6.2 Nov 19, 2014: Seegene Receives US Patent for TOCE Technology 204
10.6.3 Oct 21, 2014: GENETWORx Launches a New Personal Health Panel for Advanced Diagnosis of Genital and Gastrointestinal Pathogens 204
10.6.4 Sep 29, 2014: Trovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer 205
10.7 Strategy And Business Planning 205
10.7.1 Aug 12, 2015: CINDE Announces Pharmaceutical Invested $5.5 Million for New Headquarters 205
10.7.2 Jul 20, 2015: MedMira Opens US Subsidiary in Atlanta, GA 206
10.7.3 May 04, 2015: QIAGEN Partners With World's Largest Sequencing Provider 207
10.7.4 Jan 12, 2015: Trovagene Collaborates with UC San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients 208
10.7.5 Oct 28, 2014: NovaBiotics Establishes a US Presence 209
10.7.6 Oct 22, 2014: ERBA Diagnostics Enters Brazilian Market; Offers In Vitro Diagnostics to Hospitals, Testing Labs and Physicians Clinics 209
10.7.7 Oct 02, 2014: Quest Diagnostics Unveils New State-of-the-Art Clinical Laboratory In Marlborough, Massachusetts 209
10.7.8 Sep 26, 2014: Aethlon Medical and Exosome Sciences Announce Clinical Collaboration with Boston University CTE Center To Advance Diagnostic Candidate to Detect CTE in Former NFL Players 211
11 Appendix 212
11.1 Research Methodology 213
11.1.1 Coverage 213
11.1.2 Secondary Research 213
11.1.3 Primary Research 214
11.1.4 Company Share Analysis 214
11.1.5 Distribution Share Analysis 214
11.2 GlobalData Consulting 214
11.3 Contact Us 215
11.4 Disclaimer 215

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 14
Table 2: Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021 16
Table 3: Infectious Diagnostics Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 18
Table 4: Infectious Diagnostics Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 20
Table 5: Infectious Diagnostics Market, North America, Company Share by Revenue ($m), USD Constant, 2014 22
Table 6: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 24
Table 7: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 26
Table 8: Infectious Diagnostics Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 28
Table 9: Infectious Diagnostics Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 30
Table 10: Infectious Diagnostics Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2013-2014 31
Table 11: Infectious Diagnostics Market, Canada, Company Share by Revenue ($m), USD Constant, 2014 33
Table 12: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 35
Table 13: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 37
Table 14: Infectious Diagnostics Rapid Tests and POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 39
Table 15: Infectious Diagnostics Rapid Tests and POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 41
Table 16: Infectious Diagnostics Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2013-2014 42
Table 17: Infectious Diagnostics Market, Mexico, Company Share by Revenue ($m), USD Constant, 2014 44
Table 18: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 46
Table 19: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 48
Table 20: Infectious Diagnostics Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 50
Table 21: Infectious Diagnostics Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 52
Table 22: Infectious Diagnostics Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 53
Table 23: Infectious Diagnostics Market, United States, Company Share by Revenue ($m), USD Constant, 2014 55
Table 24: Infectious Diagnostics Market Pipeline Products 60
Table 25: Vivione Biosciences Enters into Distribution Agreement with Trillium Diagnostics 78

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2007-2021 13
Figure 2: Infectious Diagnostics Market, North America, Category Comparison by Revenue ($m), USD Constant, 2007-2021 15
Figure 3: Infectious Diagnostics Market, North America, Revenue ($m), Historic, USD Constant, 2007-2014 17
Figure 4: Infectious Diagnostics Market, North America, Revenue ($m), Forecast, USD Constant, 2014-2021 19
Figure 5: Infectious Diagnostics Market, North America, Company Share (%) 2014 21
Figure 6: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 23
Figure 7: Infectious Diagnostics Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 25
Figure 8: Infectious Diagnostics Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Historic, 2007-2014 27
Figure 9: Infectious Diagnostics Rapid Tests and POC Market, Canada, Revenue ($m), USD Constant, Forecast, 2014-2021 29
Figure 10: Infectious Diagnostics Market, Canada, Company Share (%) 2014 32
Figure 11: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 34
Figure 12: Infectious Diagnostics Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 36
Figure 13: Infectious Diagnostics Rapid Tests and POC Market, Mexico, Revenue ($m), USD Constant, Historic, 2007-2014 38
Figure 14: Infectious Diagnostics Rapid Tests and POC Market, Mexico, Revenue ($m), USD Constant, Forecast, 2014-2021 40
Figure 15: Infectious Diagnostics Market, Mexico, Company Share (%) 2014 43
Figure 16: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 45
Figure 17: Infectious Diagnostics Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 47
Figure 18: Infectious Diagnostics Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 49
Figure 19: Infectious Diagnostics Rapid Tests and POC Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 51
Figure 20: Infectious Diagnostics Market, United States, Company Share (%) 2014 54

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hemostasis Diagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts, Volume Projections for 40 Tests,  Instrumentation Review, Emerging Technologies, Opportunities for Suppliers

2016 Hemostasis Diagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts, Volume Projections for 40 Tests, Instrumentation Review, Emerging Technologies, Opportunities for Suppliers

  • $ 28500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 750 pages, 200 tables, and provides granular data and analysis not available from any other source. The report explores business and ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.